Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Sidra Medicine Welcomes First Inpatients to New Hospital Building in Doha


News provided by

Sidra Medicine

15 Jan, 2018, 11:03 GMT

Share this article

Share toX

Share this article

Share toX

DOHA, Qatar, January 15, 2018 /PRNewswire/ --

New Achievement by Qatar Foundation in Healthcare Provision Supports Country's Development  

This image opens in the lightbox
Sidra Medicine - Main Hospital (PRNewsfoto/Sidra Medicine)

Sidra Medicine, a specialty children's, young people and women's healthcare organization and member of Qatar Foundation for Education, Science and Community Development (QF), today opened its new hospital building and welcomed the first inpatients to be treated in the state-of-the-art facility.

     (Photo: https://mma.prnewswire.com/media/628561/Sidra_Medicine_Hospital.jpg )

The first inpatients to be seen by Sidra Medicine will be children requiring low-risk surgeries and women undergoing elective C-sections. These services will be ramped up through mid-2018 to include more complex pediatric surgeries, specialist pediatric services in neurology and cardiology, among others, as well as deliveries, focusing on high-risk pregnancies.

"The clinical teams at Sidra Medicine are some of the best in the world. They have been united by a passion to deliver the very best care to women, young people and children in Qatar and will be trusted partners throughout the journeys that our patients will take with us. As a state-of-the-art facility handling high-risk and specialty cases, our approach to opening is necessarily phased to allow for proper testing at each stage. The safety and comfort of our patients is of utmost importance and we look forward to welcoming them," said Sidra Medicine CEO Peter Morris.

Patients are encouraged to continue seeing their regular physicians unless they have a scheduled appointment at Sidra Medicine. No Emergency Department (ED) is currently open at Sidra Medicine and emergency cases should continue to be seen at established ED centers throughout Qatar. Sidra Medicine will open its ED in mid-2018.

"The opening of the main hospital at Sidra Medicine marks the achievement of another major milestone in the expansion of healthcare facilities in the country. The new hospital will further enhance the healthcare provided for women and children and reinforce our commitment to improving the health and wellbeing of the people in Qatar," said Minister of Public Health H.E. Dr. Hanan Mohamed Al Kuwari.

Speaking on the opening of the main hospital, Vice Chair of the Board of Governors at Sidra Medicine, Professor the Lord Darzi of Denham, said: "As part of Qatar Foundation, Sidra Medicine is a true embodiment of the country's wider, long-term efforts to build a world-class healthcare and research infrastructure in Qatar, and Her Highness Sheikha Moza bint Nasser's specific focus on transforming the care of women and children. Qatar Foundation, with Her Highness Sheikha Moza at the helm, has been a powerful force for progress. It has established Qatar as a leader in education, science and community development. We are incredibly proud to bring Her Highness's vision to life. Sidra Medicine is a first of its kind facility in the Middle East and will become a resource for the entire Gulf region in terms of specialty care for women and children supported by an impressive research infrastructure that will help lead the way in personalized medicine. I have no doubt that Sidra Medicine will become an international beacon of best practice and high-quality, academically-driven patient care."

An innovative facility designed to promote healing 

Once fully operational by mid-2018, Sidra Medicine will handle 275,000 outpatient appointments, 11,000 procedures, 100,000 emergency attendances and deliver over 9,000 babies per year, adding capacity to a rapidly growing population and delivering world-class specialist care. The hospital will include 10 operating theatres, 400 beds, 100 percent single rooms with a private bathroom, a birthing center and emergency department.

High-tech, high-touch 

As a high-tech facility, Sidra Medicine has adopted breakthrough technologies to enhance the patient experience and underpin the highest standards of care and patient safety.

Examples of the high-tech devices at Sidra Medicine include palm vein recognition technology - a biometric technology that identifies patients by capturing their vein pattern and which connects with patients' individual medical records automatically, and a 3D printer which provides models of a patient's organs such as the heart or the brain to help with treatment planning. The technology at Sidra Medicine has been developed to ensure patient data, patient experience and patient care are all maintained at the highest standards, while enabling healthcare professionals to spend more time with patients.

World-class care supported by cutting-edge research  

Medical care at Sidra Medicine is supported by research aimed at advancing the understanding of the epidemiology and mechanisms of diseases for the people of Qatar. This will help develop personalized preventative, diagnostic and therapeutic tools and improve the health outcomes of the women, young people and children of Qatar.

In line with QF's mission to make Qatar a leading center for research and development excellence and innovation, the research programs currently underway at Sidra Medicine are on par with other leading research institutions internationally. They range from delivering key milestones with the Qatar Genome Project, to patenting ways to monitor the spread of cancer using MRI technology, and reviewing the use of immunotherapy to treat breast cancer.

Regional and international referrals 

Sidra Medicine will also accept regional and international referrals for women, young people and children who need its specialist expertise. An international referrals office has already handled 117 cases from Bahrain, Egypt, Ghana, Greece, Iran, Iraq, Jordan, Kuwait, Lebanon, Nigeria, Oman, Panama, Saudi Arabia, Sudan and the UAE since Sidra Medicine opened its Outpatient Clinic in May 2016.

The most highly sought-after services have been cardiology and urology, including procedures for treating structural and congenital heart diseases, valve replacements and bladder exstrophy.

Sidra Medicine CEO Peter Morris concluded Sunday's press conference by emphasizing: "Sidra Medicine not only stands for medicine today, but medicine tomorrow, which is why our tripartite focus on patient care, biomedical research and medical education is so important. Researchers at Sidra Medicine are looking for ways to personalize care for every child, young person and mother who walks through our doors by focusing on specific aspects of their condition and personal circumstances. At the same time, our world-class healthcare professionals are sharing and spreading their knowledge and expertise to support the development of the next generation of healthcare professionals in Qatar who will care for the patients of the future."

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.